Chemistry contract research organisation Onyx Scientific has strengthened its US presence with the appointment of a Chicago-based business development director.
Dan Brisard will oversee the contract manufacturing organisation’s business development activities across the eastern half of the US.
Brisard has worked across the pharmaceutical manufacturing sector for around 15 years, including seven years with Ricerca Bioscience.
With MHRA and FDA facilities in the UK and India, Onyx Scientific assists companies from medicinal chemistry and preclinical through Phase I–III, scaling-up to large scale commercial API production.
The company has recently expanded its services to the global pharmaceutical market by forming alliances with purification and separation specialist Reach Separations and contract research and manufacturing organisation Molecular Profiles to support its end-to-end services from drug discovery through to late phase manufacturing.